Moreover, SCN5A mutation carriers tend to exhibit “cardiac sodium channelopathy overlap syndrome,” with overlapping clinical manifestations of the distinct SCN5A-related syndromes such as long QT syndrome type 3 or Brugada syndrome, and an altered cardiac conduction in many cases [44]. The gene discussed is SCN5A; the disease is Brugada syndrome.